Lexeo Therapeutics - LXEO Quarterly EPS earnings growth

Brandmark of Lexeo (LXEO)

The global disruption of biomaterial logistics is hindering international research, yet the quarterly EPS evolution reflects the resilience of Lexeo Therapeutics (LXEO), where the current metric stands at 48.90. Lexeo Therapeutics (LXEO) relies on a closed-loop gene delivery system for treating the heart and brain. Stability is guaranteed by adherence to US law and the humanitarian status of medicine, which minimizes external risks.

Lexeo Therapeutics, Inc. (LXEO) - Earnings per share growth in annualized terms for the last twelve months from 02/21/2024 to 11/14/2026

LXEO (Lexeo Therapeutics, Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Quotes lexeotx.com|LXEO - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Lexeo Therapeutics, Inc.|LXEO - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Book Value per Share Lexeo Therapeutics|LXEO - Total Stockholders' Equity|Market Value to Book Value Ratio lexeotx.com|LXEO - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Lexeo Therapeutics|LXEO - Long-Term Debt to Capital|Short-Term Debt to Equity Lexeo Therapeutics, Inc.|LXEO - Company Aggregate Indebtedness|Debts to Book Capitalization Lexeo|LXEO - Long-Term Debt|Company Current Liabilities Lexeo Therapeutics|Quick Liquidity Indicator lexeotx.com
- earnings and valuation multiples indicators:
LXEO - Profit After Payment of Taxes|Projected Future Earnings Lexeo Therapeutics|LXEO - Business Payback Period|Forward P/E Multiple Lexeo|LXEO - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lexeo Therapeutics Inc.|LXEO - Operating income before deduction of amortization|Earnings per share for the last twelve months Lexeo Therapeutics|LXEO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months lexeotx.com|LXEO - Earnings per share growth this year|Earnings growth forecast for next year Lexeo Therapeutics
- sales volume and revenue indicators:
LXEO - Company Total Revenue|Company Projected Revenue lexeotx.com|LXEO - Price to Sales|Forward P/S Multiple Lexeo Therapeutics Inc.
General company analysis:Lexeo Therapeutics Inc. - LXEO
Flagship merchandise of lexeotx.com

Lexeo Therapeutics' unique developments in AAV vectors for Alzheimer's therapy create a long-term patent barrier. The effectiveness of this strategy is reflected in comparable quarterly EPS growth, which currently stands at 48.90. This metric measures net income per share dynamics, revealing the business's ability to offset rising operating expenses. It is critical for investors to distinguish between sales scaling and artificial cost-cutting. Analysis of this curve confirms the asset's fundamental stability.

Analysis of competing companies

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)